$CURR CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins https://finance.yahoo.com/news/cure-pharmaceutical-reports-third-quarter-110000414.html